MARKET

FIXX

FIXX

Homology Medicines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.38
+0.58
+4.20%
Opening 15:03 10/15 EDT
OPEN
13.84
PREV CLOSE
13.80
HIGH
14.68
LOW
13.61
VOLUME
119.23K
TURNOVER
--
52 WEEK HIGH
31.80
52 WEEK LOW
13.52
MARKET CAP
632.23M
P/E (TTM)
-6.6980
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of FIXX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

FIXX News

  • The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings
  • Benzinga.7h ago
  • Stocks That Hit 52-Week Lows On Monday
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout
  • Benzinga.4d ago
  • Stocks That Hit 52-Week Lows On Thursday
  • Benzinga.5d ago

More

Industry

Biotechnology & Medical Research
+2.03%
Pharmaceuticals & Medical Research
+1.31%

Hot Stocks

Name
Price
%Change

About FIXX

Homology Medicines, Inc. is a genetic medicines company translating gene editing and gene therapy technology into treatments for patients with rare diseases. The Company is focused on developing a pipeline of new medicines that address and cure the underlying cause of monogenic diseases in the liver, central nervous system (CNS), bone marrow, lung and the eye. The Company’s lead product candidate, HMI-102 is a gene therapy for the treatment of phenylketonuria (PKU). Its PKU program is focused on adults using the gene therapy approach. The Company’s suite of 15 adeno-associated virus vectors (AAVHSCs) enables it to focus on a method of gene editing called gene correction. The Company’s diverse set of AAVHSCs allows it to precisely target, via a single intravenous injection, a wide range of disease-relevant tissues, including the liver, central nervous system, or CNS, bone marrow, lung, muscle and eye, across both modalities - gene editing and gene therapy.
More

Webull offers Homology Medicines Inc (FIXX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.